CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition) 期刊论文
2019, 卷号: 12, 期号: 1, 页码: 16
作者:  Li, Jian;  Yuan, Ying;  Yang, Fan;  Wang, Yi;  Zhu, Xu
收藏  |  浏览/下载:43/0  |  提交时间:2020/01/03
Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 16
作者:  Huang, Jing;  Xu, Binghe;  Liu, Ying;  Huang, Junxing;  Lu, Ping
收藏  |  浏览/下载:31/0  |  提交时间:2020/01/03
Optimal regimen of trastuzumab in combination with oxaliplatin/capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial 期刊论文
2016, 卷号: 16, 页码: 68
作者:  Gong, Jifang;  Liu, Tianshu;  Fan, Qingxia;  Bai, Li;  Bi, Feng
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/04
A multicenter, phase II study of trastuzumab plus capecitabine and oxaliplatin (XELOX) as first-line chemotherapy for HER2-positive advanced gastric cancer: Update results of efficacy and toxicity. 期刊论文
2014, 卷号: 32, 期号: 3
作者:  Gong, Jifang;  Liu, Tianshu;  Fan, Qingxia;  Bai, Li;  Bi, Feng
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/13
A multicenter, phase II study of trastuzumab plus capecitabine and oxaliplatin (XELOX) as first-line chemotherapy for HER2-positive advanced gastric cancer: Update results of efficacy and toxicity. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2014-01-20
作者:  Gong, Jifang;  Liu, Tianshu;  Fan, Qingxia;  Bai, Li;  Bi, Feng
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace